OSR Holdings, Inc. Share Price
OSRHOSR Holdings, Inc. Stock Performance
Open $0.54 | Prev. Close $0.55 | Circuit Range N/A |
Day Range $0.53 - $0.58 | Year Range $0.47 - $11.84 | Volume 1,297 |
Average Traded $0.55 |
OSR Holdings, Inc. Share Price Chart
About OSR Holdings, Inc.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
OSR Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $0.54 | $0.56 | +6.72% |
05-Feb-26 | $0.56 | $0.52 | -11.24% |
04-Feb-26 | $0.59 | $0.59 | +0.69% |
03-Feb-26 | $0.59 | $0.58 | +3.19% |
02-Feb-26 | $0.59 | $0.56 | -5.04% |
30-Jan-26 | $0.65 | $0.59 | -9.30% |
29-Jan-26 | $0.66 | $0.66 | +4.96% |